Mark Lappe

Mark Lappe does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include REPROS THERAPEUTICS INC., AEOLUS PHARMACEUTICALS, INC., Inhibrx, Inc., and Inhibrx Biosciences, Inc..

2008 was Mark Lappe's most active year for acquiring shares with 2 total transactions. Mark Lappe's most active month to acquire stocks was the month of December. 2024 was Mark Lappe's most active year for disposing of shares, totalling 2 transactions. Mark Lappe's most active month to dispose stocks was the month of April. 2008 saw Mark Lappe paying a total of $508,000.00 for 80,000 shares, this is the most they've acquired in one year. In 2024 Mark Lappe cashed out on 245,000 shares for a total of $0.00, their largest year based on trade value.